← Leaderboards
Rui Su
Beckman Research Institute/City Of Hope
$1,365,394
Attributed
$1,365,394
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $922.2K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,365,394 · 2
By mechanism
R37$877,852 · 1
R01$487,542 · 1
Top collaborators
No co-investigators on record.
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Jianjun Chen$21,393,583
- Guido Marcucci$19,718,636
- Chun-Wei David Chen$8,071,175
- Ling Li$7,488,116
- Susanta K Hui$5,584,345
Others in their field
Other Rising Stars on “In Vitro”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Warwick Britton · University Of Sydney$10,964,476
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
Research focus
In VitroModificationHematopoieticInhibitorLeukemogenesisMll-Rearranged LeukemiaFlt3 GeneGrowthHematopoietic NeoplasmsHigh RiskLeukemic Stem CellBone Marrow TransplantationMedicalMethyltransferaseAcute Myelocytic LeukemiaDruggable TargetCellsFrequenciesBiologicalAcute Myeloid Leukemia CellBiological ProcessClonal ExpansionIn VivoMolecular
Grant awards (3)
Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia$487,542
R01 · FY2025 · CA · contact PI
The role, mechanism, and therapeutic potential of METTL1 in acute myeloid leukemia$434,632
R37 · FY2025 · CA · contact PI
The role, mechanism, and therapeutic potential of METTL1 in acute myeloid leukemia$443,220
R37 · FY2024 · CA · contact PI